Mohamed F Doheim: Bridging Therapy Improves Outcomes in M2 MCA Occlusions
Mohamed F Doheim, Faculty Instructor (Research) at NIH StrokeNet, shared a post on X:
”Proud to share our new study in Stroke AHA/ASA. In patients with M2 MCA occlusions, bridging therapy (IVT+EVT) was associated with better 90-day functional outcomes compared to EVT alone, with no major safety concerns.”
Read the full article here.
Title: Direct Endovascular Versus Bridging Therapy in M2 Segment Occlusion of Middle Cerebral Artery: A MR CLEAN Registry Study
Authors: Mohamed F. Doheim, Robrecht R.M.M. Knapen, Julie Staals, Wouter J. Schonewille, Diederik W.J. Dippel, Adriaan C.G.M. van Es, Hester F. Lingsma, Christiaan van der Leij, Charles B. Majoie, Raul G. Nogueira, Robert J. van Oostenbrugge, Wim H. van Zwam
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity